NEWARK, Calif., Nov. 5, 2013 /PRNewswire/ -- Depomed, Inc. (DEPO) today reported financial results for the quarter ended September 30, 2013.
Third Quarter 2013 Financial and Operational Summary
•Total revenues were $37.5 million and included recognition of a $5.0 million milestone payment from Mallinckrodt related to the NDA filing of MNK-795.
Help employers find you! Check out all the jobs and post your resume.
